The Cigna Group posted strong Q3 2024 results, yet CI stock is down nearly 20% from its 52-week high. See why this may ...

Ballad Health and Cigna are working to finalize negotiations as a New Year’s Eve deadline looms to keep some of the insurance ...

Cigna reported better-than-expected earnings Thursday and maintained its full-year guidance, lifting the shares.

Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street ...

The Cigna Group on Thursday reported a nearly $740 million profit for the third quarter of 2024, despite an after-tax loss of ...

Ballad Health facilities and providers could soon be considered "out-of-network" for those carrying Cigna Healthcare insurance. Negotiations between Ballad and Cigna for the insurance to remain ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Voyager Therapeutics (VYGR – Research Report), Align Tech ...

TD Cowen analyst Ryan Langston has maintained their bullish stance on CI stock, giving a Buy rating today. Ryan Langston’s rating is ...

On Thursday, Cigna Group (CI) stock saw a modest uptick, ending the day at $318.24 which represents a slight increase of $0.67 or 0.21% from the prior close of $317.57. The stock opened at $318.67 and ...

Health insurance company Cigna Group (CI) topped revenue and profit estimates in its third quarter earnings results, while the company reaffirmed its full-year outlook Morning Brief anchors Julie ...

Health insurance companies are counting on specialty pharmacy to invigorate their finances as other business lines face headwinds.

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.